Raymond James Financial Inc. decreased its holdings in shares of Clarivate PLC (NYSE:CLVT - Free Report) by 13.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,267,539 shares of the company's stock after selling 506,391 shares during the quarter. Raymond James Financial Inc. owned about 0.48% of Clarivate worth $12,841,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Bessemer Group Inc. bought a new stake in Clarivate during the 1st quarter valued at $30,000. Millstone Evans Group LLC increased its holdings in shares of Clarivate by 156.6% in the first quarter. Millstone Evans Group LLC now owns 7,545 shares of the company's stock worth $30,000 after purchasing an additional 4,605 shares during the period. MQS Management LLC bought a new position in shares of Clarivate in the first quarter worth $44,000. Essex Financial Services Inc. bought a new position in shares of Clarivate in the first quarter worth $45,000. Finally, Schonfeld Strategic Advisors LLC bought a new position in shares of Clarivate in the fourth quarter worth $56,000. Institutional investors own 85.72% of the company's stock.
Insider Transactions at Clarivate
In related news, insider James Gordon Samson sold 100,000 shares of the stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total value of $453,000.00. Following the completion of the transaction, the insider directly owned 1,271,103 shares of the company's stock, valued at $5,758,096.59. This represents a 7.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 23.18% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
CLVT has been the subject of several research reports. Jefferies Financial Group initiated coverage on shares of Clarivate in a research report on Friday, July 18th. They issued a "hold" rating and a $4.50 target price for the company. Wall Street Zen lowered shares of Clarivate from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Three investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Clarivate presently has an average rating of "Reduce" and a consensus target price of $4.83.
Read Our Latest Stock Report on CLVT
Clarivate Stock Performance
Clarivate stock opened at $4.38 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.90. The firm has a 50-day moving average of $4.25 and a 200-day moving average of $4.16. The firm has a market cap of $2.94 billion, a P/E ratio of -7.06 and a beta of 1.40. Clarivate PLC has a 1-year low of $3.04 and a 1-year high of $7.15.
Clarivate (NYSE:CLVT - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.18 earnings per share for the quarter, hitting analysts' consensus estimates of $0.18. The company had revenue of $621.40 million during the quarter, compared to analyst estimates of $587.17 million. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. Clarivate's revenue for the quarter was down 4.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. Sell-side analysts expect that Clarivate PLC will post 0.63 EPS for the current year.
About Clarivate
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
